Association of hyperglycaemia at-admission & diabetes mellitus with 28 day mortality in patients admitted with moderate-severe SARS-CoV-2 infection: A retrospective study

Kurian, Navya Mary; Yadav, Subhash Chandra B.; Gurjar, Mohan; Mishra, Prabhakar; Sanjeev, Om P.; Azim, Afzal; Gupta, Devendra; Hashim, Zia; Verma, Alka; Bhatia, Eesh; Ghatak, Tanmoy; Singh, Ratender Kumar; Nath, Alok; Sahoo, Saroj Kumar; Dabadghao, Preeti; Gupta, Sushil.
Artículo | IMSEAR | ID: sea-223628

Documentos relacionados

  1. Association of hyperglycaemia at-admission & diabetes mellitus with 28 day mortality in patients admitted with moderate-severe SARS-CoV-2 infection: A retrospective study.
  2. [Drug therapy interventions for acute SARS-CoV-2 infection: who, when, and what?]
  3. [The profile of serum inflammatory biomarkers in patients with SARS-CoV-2 infection: how well do they reflect the presence of pulmonary involvement?]
  4. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
  5. [Multisystemic inflammatory syndrome in children after severe acute respiratory syndrome coronavirus 2 infection: a clinical analysis of four cases].
  6. Tocilizumab: A retrospective multi-center cohort study of critically ill patients with COVID-19.
  7. [Drug therapy interventions for acute SARS-CoV-2 infection: who, when, and what?]
  8. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
  9. Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection.
  10. [Feline leukemia virus infection: importance and current situation in Switzerland].